Brief: Biofrontera Inc Says Revenues For The Q4 2022 Are Anticipated To Be In The Range Of About $10.2 Mln To $10.4 Mln
09/01/2023 13:50
Jan 9 (Reuters) - Biofrontera Inc BFRI.O :
* BIOFRONTERA INC - REVENUES FOR THE FOURTH QUARTER OF 2022
ARE
ANTICIPATED TO BE IN THE RANGE OF APPROXIMATELY $10.2 MILLION TO
$10.4 MILLION
Source text for Eikon: ID:
Further company coverage: BFRI.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales